Analyzing the data indicates 3 tests performed on angimmune.com's operability in the 1 740 days from July 2, 2021, forward. Angimmune.com was operable 2 times from the total tests performed, last recorded on August 14, 2021, with a 200 response code. When evaluated, angimmune.com was offline 33.33% times, which comes out to 1 times total, with the latest of which was on August 13, 2021. All replies received as of April 8, 2026, indicate that no responses with an error status have been received. Data indicates angimmune.com responded in 7.100 seconds on August 14, 2021, against its 6.915 seconds average.
| United States | 100.00% | ||||||||
| 21:41 | |||||||||
| Site | Total Checks | Last Modified |
|---|---|---|
| 1 | March 9, 2024 | |
| 1 | April 8, 2026 | |
| 3 | July 2, 2021 | |
| 1 | April 8, 2026 | |
| 1 | April 8, 2026 |
Fridae.asia | Angimmune.com | ||||
|---|---|---|---|---|---|
| Page Title |
|---|
| Angimmune LLC - Developer of Resimmune™, an Anti-T Cell Immunotoxin Length: 73 characters |
| Meta Description |
| Sponsor of Cutaneous T-cell Lymphoma clinical trial using A-dmDT390-bisFv (UCHT1) immunomodulation therapy for T-cell, cancer, and autoimmune diseases. Length: 151 characters |
| Meta Keywords |
| no meta keywords data for angimmune.com 2026-04-08T04:15:25+00:00 |
| Page Content |
| Web Page Content Length: 7908 characters |
| H1 Heading |
| no h1 heading data for angimmune.com 2026-04-08T04:15:25+00:00 |
| H2 Headings |
| Angimmune's anti- CD3 immunotoxin is being investigated for treatment of Cutaneous T-Cell Lymphoma (CTCL), Combination Immunotherapy, and a new Immunotherapeutic approach to prevent Organ Transplant Rejection Count: 1 heading tag |
| H3 Headings |
| T cell Targeting for Cancer, Autoimmune Disease, and Induction Immunotherapy Count: 1 heading tag |
| H4 Headings |
| A New Method to Induce Immunomodulation Applications & Advantages Translation of a Novel Induction Therapy for Transplantation to Prevent Antibody Mediated Rejection Licensing & Collaboration Count: 4 heading tag |
| H5-H6 Headings |
| no h5-h6 headings data for angimmune.com 2026-04-08T04:15:25+00:00 |
| Image ALT Attributes |
| no image alt attributes data for angimmune.com 2026-04-08T04:15:25+00:00 |
| Robots.txt |
| no robots.txt data for angimmune.com 2026-04-08T04:15:25+00:00 |
| XML Sitemap |
| no xml sitemap data for angimmune.com 2026-04-08T04:15:25+00:00 |
| Page Size |
| page size: 8 kb |
| Response Time |
| response time: 6.915 sec |
| Minify CSS |
| Minified: css/style.css css/fancybox.min.css css/mediaelementplayer.min.css Unminified: //fonts.googleapis.com/css?family=Open+Sans:400,600,300,800,700,400italic|PT+Serif:400,400italic included in the page |
| Minify JavaScript |
| Minified: js/modernizr.custom.js //ajax.googleapis.com/ajax/libs/jquery/1.7.1/jquery.min.js js/respond.min.js js/jquery.easing-1.3.min.js js/jquery.fancybox-1.3.4.pack.js js/jquery.smartStartSlider.min.js js/jquery.jcarousel.min.js js/jquery.cycle.all.min.js js/jquery.isotope.min.js js/mediaelement-and-player.min.js js/jquery.gmap.min.js js/jquery.touchSwipe-1.2.5.min.js js/custom.js detected during site scan |
| Structured Data |
| no structured data data for angimmune.com 2026-04-08T04:15:25+00:00 |
| CDN Usage |
| no cdn usage data for angimmune.com 2026-04-08T04:15:25+00:00 |
| SSL certificates |
| SSL is enabled on the website |